CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

June 15, 2026 · Phase 3 readout

RVMD Phase 3 readout: a positive outcome, +41.3%

On June 15, 2026, RMC-6236 — Revolution Medicines, Inc. (Colorectal Cancer) reached its Phase 3 readout. The result was a positive outcome, and the stock moved +41.3% in the window around the event.

The move

$96.43
1d before
$136.30
Event day
$147.01
1d after
$148.63
5d after

Pre-catalyst setup

+1.7%
30-day run-up
2960%
30-day volatility
1.1×
volume spike